Vimarsana
Biggest News Aggregation in the World

Page 3 - Its Evernorth News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Its Evernorth. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Its Evernorth Today - Breaking & Trending Today

Cigna (NYSE:CI) Releases FY 2022 Earnings Guidance - Vimarsana News

Cigna (NYSE:CI) Releases FY 2022 Earnings Guidance

Cigna (NYSE:CI – Get Rating) issued an update on its FY 2022 earnings guidance on Monday morning. The company provided EPS guidance of $22.60- for the period, compared to the consensus EPS estimate of $22.70. The company issued revenue guidance of $177.00B-, compared to the consensus revenue estimate of $178.34 billion. NYSE CI opened at […]

Cigna Co. (NYSE:CI) Receives Average Recommendation of "Buy" from Analysts - Vimarsana News

Cigna Co. (NYSE:CI) Receives Average Recommendation of "Buy" from Analysts

Shares of Cigna Co. (NYSE:CI – Get Rating) have earned a consensus recommendation of “Buy” from the twenty-seven analysts that are presently covering the firm, Marketbeat.com reports. Five equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the […]

Jefferies Financial Group Weighs in on Cigna Co.'s Q2 2022 Earnings (NYSE:CI) - Vimarsana News

Jefferies Financial Group Weighs in on Cigna Co.'s Q2 2022 Earnings (NYSE:CI)

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.

Morgan Stanley Increases Cigna (NYSE:CI) Price Target to $283.00 - Vimarsana News

Morgan Stanley Increases Cigna (NYSE:CI) Price Target to $283.00

Cigna (NYSE:CI – Get Rating) had its price target boosted by investment analysts at Morgan Stanley from $235.00 to $283.00 in a report released on Friday, Stock Target Advisor reports. The firm currently has an “equal weight” rating on the health services provider’s stock. Morgan Stanley’s price target would indicate a potential upside of 5.25% […]

Cigna (NYSE:CI) Research Coverage Started at Sanford C. Bernstein - Vimarsana News

Cigna (NYSE:CI) Research Coverage Started at Sanford C. Bernstein

Sanford C. Bernstein assumed coverage on shares of Cigna (NYSE:CI – Get Rating) in a research report issued on Thursday, The Fly reports. The brokerage set a “market perform” rating on the health services provider’s stock. A number of other analysts have also weighed in on the stock. StockNews.com assumed coverage on shares of Cigna […]